Abstract
Endoscopic studies with nabumetone have consistently shown a lower incidence of gastro-duodenal erosive lesions than comparable non-steroidal anti-inflammatory drugs (NSAIDs) including naproxen and ibuprofen.
MeSH terms
-
Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
-
Butanones / adverse effects*
-
Butanones / therapeutic use
-
Controlled Clinical Trials as Topic
-
Digestive System / drug effects*
-
Digestive System / pathology
-
Gastroscopy
-
Humans
-
Indomethacin / adverse effects
-
Indomethacin / therapeutic use
-
Nabumetone
-
Naproxen / adverse effects
-
Naproxen / therapeutic use
-
Prospective Studies
-
Randomized Controlled Trials as Topic
-
Rheumatic Diseases / drug therapy*
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Butanones
-
Naproxen
-
Nabumetone
-
Indomethacin